Compile Data Set for Download or QSAR
Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 50012865
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123521([2'-(2-Pyridin-2-yl-ethylcarbamoyl)-biphenyl-2-ylm...)
Affinity DataIC50: 160nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123525([2'-(1-Carbamoyl-3-methyl-butylcarbamoyl)-biphenyl...)
Affinity DataIC50: 300nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123507(2'-[(3-Phenyl-butyrylamino)-methyl]-biphenyl-2-car...)
Affinity DataIC50: 300nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123528({2-[2-(Cyclopropylmethyl-carbamoyl)-pyridin-3-yl]-...)
Affinity DataIC50: 400nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 3(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123521([2'-(2-Pyridin-2-yl-ethylcarbamoyl)-biphenyl-2-ylm...)
Affinity DataIC50: 500nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.3 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123511([6,6'-Dimethyl-2'-(2-pyridin-2-yl-ethylcarbamoyl)-...)
Affinity DataIC50: 700nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123511([6,6'-Dimethyl-2'-(2-pyridin-2-yl-ethylcarbamoyl)-...)
Affinity DataIC50: 700nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123508([2'-(2-Pyridin-2-yl-ethylcarbamoyl)-biphenyl-2-ylm...)
Affinity DataIC50: 700nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123518([2'-(3-Methyl-butylcarbamoyl)-biphenyl-2-ylmethyl]...)
Affinity DataIC50: 800nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123510(2'-[(3-Phenyl-butyrylamino)-methyl]-biphenyl-2-car...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123529([6,6'-Dimethyl-2'-(3-methyl-butylcarbamoyl)-biphen...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123529([6,6'-Dimethyl-2'-(3-methyl-butylcarbamoyl)-biphen...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123530([2'-(2,4-Difluoro-benzylcarbamoyl)-biphenyl-2-ylme...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123519(2'-{[2-(4-Methoxy-phenyl)-acetylamino]-methyl}-bip...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123531([2'-(3-Dimethylamino-2,2-dimethyl-propylcarbamoyl)...)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 3(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123508([2'-(2-Pyridin-2-yl-ethylcarbamoyl)-biphenyl-2-ylm...)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.3 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123524([2'-(2-Pyridin-2-yl-ethylcarbamoyl)-biphenyl-2-ylm...)
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123533(2'-(Benzenesulfonylamino-methyl)-biphenyl-2-carbox...)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123516({2-[2-(3-Methyl-butylcarbamoyl)-pyridin-3-yl]-benz...)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123515([2'-(3-Methyl-butylcarbamoyl)-biphenyl-2-ylmethyl]...)
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123512([2'-(3-Methyl-butylcarbamoyl)-biphenyl-2-ylmethyl]...)
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123513(2'-(Phenethylamino-methyl)-biphenyl-2-carboxylic a...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123534(2'-(Benzoylamino-methyl)-biphenyl-2-carboxylic aci...)
Affinity DataIC50: 4.10E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123522(2'-[(3-Phenyl-ureido)-methyl]-biphenyl-2-carboxyli...)
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123527(2'-[(3-Trifluoromethyl-benzenesulfonylamino)-methy...)
Affinity DataIC50: 4.80E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123517({4-[2-(3-Methyl-butylcarbamoyl)-phenyl]-pyridin-3-...)
Affinity DataIC50: 7.00E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123523([2'-(3-Methyl-butylcarbamoyl)-biphenyl-2-ylmethyl]...)
Affinity DataIC50: 7.10E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123509(2'-[(4-Acetyl-benzenesulfonylamino)-methyl]-biphen...)
Affinity DataIC50: 7.70E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123526({2-[3-(3-Methyl-butylcarbamoyl)-pyridin-2-yl]-benz...)
Affinity DataIC50: 7.80E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123514(2'-[(Naphthalene-1-sulfonylamino)-methyl]-biphenyl...)
Affinity DataIC50: 9.10E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123520(8-(4-Chloro-benzenesulfonylamino)-naphthalene-1-ca...)
Affinity DataIC50: 9.50E+3nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123532(2'-[(Naphthalene-1-sulfonylamino)-methyl]-biphenyl...)
Affinity DataIC50: 1.12E+4nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123535({2-[4-(3-Methyl-butylcarbamoyl)-pyridin-3-yl]-benz...)
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed